Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice (Q46317296)

21 December 2017

title

Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice (English)

1 reference

21 December 2017

main subject

fatty acid

0 references

author name string

Atsuko Kamijo-Ikemori

1

1 reference

21 December 2017

Takeshi Sugaya

2

1 reference

21 December 2017

Ayako Sekizuka

3

1 reference

21 December 2017

Kazuaki Hirata

4

1 reference

21 December 2017

Kenjiro Kimura

5

1 reference

21 December 2017

language of work or name

English

0 references

publication date

14 October 2008

1 reference

21 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

21 December 2017

volume

24

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

788-800

1 reference

21 December 2017

Tubulointerstitial changes as a major determinant in the progression of renal damage

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Structural and functional features of different types of cytoplasmic fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Structural and functional aspects of cytosolic fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Amelioration of diabetic nephropathy in SPARC-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

A simple fluorometric assay for lipoperoxide in blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Overexpression of angiotensinogen increases tubular apoptosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Identification and quantification of N(epsilon)-(Hexanoyl)lysine in human urine by liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Increase in oxidative stress in kidneys of diabetic Akita mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Urinary fatty acid binding protein in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Immunolocalization of antioxidant enzymes in adult hamster kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

An imbalance in antioxidant defense affects cellular function: the pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (Gpx1) knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN573

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN573

1 reference

21 December 2017

PubMed ID

18854419

1 reference

21 December 2017